Cell Culture

First Human Trial Tests Stem Cells for Huntington’s Disease
Research & Development First Human Trial Tests Stem Cells for Huntington’s Disease

The relentless progression of Huntington’s disease has long stood as one of the most daunting challenges in modern neurology, leaving families without any effective way to halt the decay of the human mind. For decades, the medical community struggled to offer anything beyond palliative care,

AIST Unveils New Fingerprinting Method for Biomanufacturing
Biotech & Bioprocessing AIST Unveils New Fingerprinting Method for Biomanufacturing

The National Institute of Advanced Industrial Science and Technology (AIST) has introduced a transformative analytical technique designed to redefine how manufacturers assess the quality and consistency of culture media. This innovation utilizes a sophisticated fingerprinting approach to capture

APAC Plants Tackle Critical Bioprocessing Bottlenecks
Management & Regulatory APAC Plants Tackle Critical Bioprocessing Bottlenecks

Operating a modern biopharmaceutical facility in the Asia-Pacific region feels less like solving a static puzzle and more like managing a pressurized hydraulic system where fixing a leak in one valve inevitably increases the strain on the next. Engineers and plant managers across the region are

CellOrigin Advances Next-Gen Cell Therapy for Solid Tumors
Biotech & Bioprocessing CellOrigin Advances Next-Gen Cell Therapy for Solid Tumors

The current oncology landscape faces a persistent bottleneck as traditional chimeric antigen receptor T-cell therapies continue to struggle with the immunosuppressive defenses of solid tumors. While liquid cancers have seen remarkable recovery rates, the dense extracellular matrix and hostile

How Will UMSOM Advance Pediatric Gene and Cardiac Care?
Research & Development How Will UMSOM Advance Pediatric Gene and Cardiac Care?

The urgency of modern medical innovation is never more apparent than in the specialized field of pediatric care, where rare genetic disorders and complex congenital heart defects require immediate and highly sophisticated intervention. To address these critical needs, the University of Maryland

How Can We Master High-Density CHO Cell Scale-Up?
Management & Regulatory How Can We Master High-Density CHO Cell Scale-Up?

The biopharmaceutical landscape in 2026 operates as a high-stakes arena where the efficiency of protein production directly determines the accessibility of life-saving treatments for millions of patients. Central to this enterprise are Chinese hamster ovary (CHO) cells, which currently serve as the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later